China’s retaliatory tariffs on US could mean more headwinds for drugmakers

China’s announcement of 34% tariffs on all US imports — a retaliation against US tariffs that were announced this week — could create more challenges for drugmakers already navigating a dampened Chinese market and increased competition there.